N

NuCana plc
D

NCNA

1.56000
USD
-0.02
(-1.27%)
مغلق
حجم التداول
0
الربح لكل سهم
0
العائد الربحي
0
P/E
-0
حجم السوق
3,504,384
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    AMGN
    2.78
    (0.84%)
    295.935 USD
    B
    BIIB
    -2.500
    (-1.17%)
    210.710 USD
    C
    CRSP
    -2.450
    (-4.28%)
    54.840 USD
    E
    EDIT
    -0.28500
    (-5.26%)
    5.13500 USD
    GILD
    0.470
    (0.62%)
    76.510 USD
    I
    ILMN
    -0.250
    (-0.20%)
    122.370 USD
    I
    INCY
    -0.680
    (-1.05%)
    64.390 USD
    MRNA
    -25.020
    (-20.99%)
    94.160 USD
    REGN
    13.14
    (1.22%)
    1,091.19 USD
    VRTX
    9.75
    (1.97%)
    484.2 USD
    المزيد
الأخبار
المقالات

العنوان: NuCana plc

القطاع: Healthcare
الصناعة: Biotechnology
NuCana PLC is a biopharmaceutical company focused on improving treatment outcomes for cancer patients by ProTide technology. Utilizing proprietary ProTide technology, the firm is developing new medicines designed to overcome key cancer resistance mechanisms and generate much higher concentrations of anti-cancer metabolites in cancer cells. The company's ProTide pipeline products are NUC-3373, NUC-7738, Acelarin. Geographically operates through the region of the United States.